Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial
about
Outcomes after (90) Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis.Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma.Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.
P2860
Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Autologous stem cell transplan ...... enter, phase II clinical trial
@ast
Autologous stem cell transplan ...... enter, phase II clinical trial
@en
type
label
Autologous stem cell transplan ...... enter, phase II clinical trial
@ast
Autologous stem cell transplan ...... enter, phase II clinical trial
@en
prefLabel
Autologous stem cell transplan ...... enter, phase II clinical trial
@ast
Autologous stem cell transplan ...... enter, phase II clinical trial
@en
P2093
P2860
P50
P1433
P1476
Autologous stem cell transplan ...... enter, phase II clinical trial
@en
P2093
Antonio Torres
Carlos Grande
Carlos Panizo
Dolores Caballero
Dulce López
Francisca Palmero
Grupo Español de Linfomas y Trasplante Autologo de Médula Ósea (GELTAMO)
Isidro Jarque
José A García-Marco
José F Tomás
P2860
P356
10.3324/HAEMATOL.2014.108308
P577
2014-07-01T00:00:00Z